Updates

Get Alerts
May 12, 2023 | Hurst's the Heart Updates
TRILUMINATE Pivotal Trial
Anton Camaj, Tara Naib
May 12, 2023 | Hurst's the Heart Updates
STOP-CA: Does statin therapy mitigate the risk of developing anthracycline-induced cardiotoxicity?
Andrew Armanious, Gina LaRocca
May 12, 2023 | Hurst's the Heart Updates
STELLAR: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
Lindsey R. Mitrani, Anuradha Lala
May 12, 2023 | Hurst's the Heart Updates
Anticoagulation Strategies in Non-Critically Ill Patients Hospitalized with COVID-19: A Randomized Clinical Trial (FREEDOM COVID)
David A. Power, Martin E. Goldman
May 12, 2023 | Hurst's the Heart Updates
Three-Year Outcomes After Transcatheter or Surgical Aortic Valve Replacement in Low-Risk Patients with Aortic Stenosis: The Evolut Low Risk Trial
Kevin Schesing, Matthew Tomey
May 12, 2023 | Hurst's the Heart Updates
MitraClip Continues to Outperform Medical Therapy Alone at 5-years, but Event Rates Remain High
Kevin Soriano, Gregory Serrao
May 12, 2023 | Hurst's the Heart Updates
CLEAR Outcomes: Bempedoic Acid and Cardiovascular Outcomes in Statin Intolerant Patients
Waqas A. Malick, Jeffrey I. Mechanick
May 12, 2023 | Hurst's the Heart Updates
BIOVASC: Immediate Versus Staged Complete Revascularization in ACS and Multivessel Disease
Solomon W. Bienstock, Javier Sanz
March 6, 2023 | Hurst's the Heart Updates
TRANSFORM-HF: Is torsemide superior to furosemide in improving survival among patients treated for decompensated heart failure?
Andrew Armanious, Tara Naib
March 6, 2023 | Hurst's the Heart Updates
SPORT Trial: Supplements, Placebo, or Rosuvastatin
Solomon W. Bienstock, Gina LaRocca
March 6, 2023 | Hurst's the Heart Updates
RESPECT EPA Trial
Anton Camaj, Martin E. Goldman
March 6, 2023 | Hurst's the Heart Updates
OCEAN(a) DOSE: Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease
Waqas A. Malick, Jeffrey I. Mechanick
March 6, 2023 | Hurst's the Heart Updates
Survival After Invasive or Conservative Management of Stable Coronary Disease: The ISCHEMIA EXTEND Interim Report (ISCHEMIA-EXTEND)
David A. Power, Matthew I. Tomey
March 6, 2023 | Hurst's the Heart Updates
Effectiveness of Intravenous Iron Treatment Versus Standard Care in Patients With Heart Failure and Iron Deficiency (IRONMAN)
David A. Power, Anuradha Lala-Trindade
March 6, 2023 | Hurst's the Heart Updates
EMPA-KIDNEY: Empagliflozin and Chronic Kidney Disease
Solomon W. Bienstock, Jacob Koruth
March 6, 2023 | Hurst's the Heart Updates
BRIGHT-4: a randomized trial of bivalirudin in patients with ST-segment elevation myocardial infarction
Kevin Schesing, Gregory Serrao
March 6, 2023 | Hurst's the Heart Updates
BEST-CLI: Which Revascularization Technique is Best?
Kevin Soriano, Daniella Kadian-Dodov
October 13, 2022 | Hurst's the Heart Updates
SECURE Trial
Anton Camaj, Martin E. Goldman
October 13, 2022 | Hurst's the Heart Updates
Study Summary: REVIVED-BCIS2
Kevin Soriano, Matthew I. Tomey
October 13, 2022 | Hurst's the Heart Updates
PANTHER: What is the optimal antiplatelet monotherapy for established coronary artery disease?
Andrew Armanious, Gregory Serrao
October 13, 2022 | Hurst's the Heart Updates
SGLT2 Inhibitors in Patients with Heart Failure: a Comprehensive Meta-Analysis
Kevin Schesing, Tara Naib
October 13, 2022 | Hurst's the Heart Updates
Rivaroxaban in Rheumatic Heart Disease Associated Atrial Fibrillation: The INVICTUS trial
David A. Power, Jacob S. Koruth
October 13, 2022 | Hurst's the Heart Updates
DELIVER: Dapagliflozin in Patients with Mildly Reduced or Preserved Ejection Fraction
Solomon W. Bienstock, Anuradha Lala-Trindade
October 13, 2022 | Hurst's the Heart Updates
DANCAVAS: Five-Year Outcomes of the Danish Cardiovascular Screening Trial
Waqas A. Malick, Jeffrey I. Mechanick
June 27, 2022 | Hurst's the Heart Updates
VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM Eligible for Septal Reduction Therapy
Solomon W. Bienstock, Martin E. Goldman